Guangyan Lei
About
In The Last Decade
Guangyan Lei
20 papers receiving 288 citations
Peers
Comparison fields: 5 of 61
- Molecular Biology 108
- Biomedical Engineering 80
- Oncology 79
- Surgery 77
- Cancer Research 75
Countries citing papers authored by Guangyan Lei
This map shows the geographic impact of Guangyan Lei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangyan Lei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangyan Lei more than expected).
Fields of papers citing papers by Guangyan Lei
This network shows the impact of papers produced by Guangyan Lei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangyan Lei. The network helps show where Guangyan Lei may publish in the future.
Co-authorship network of co-authors of Guangyan Lei
This figure shows the co-authorship network connecting the top 25 collaborators of Guangyan Lei. A scholar is included among the top collaborators of Guangyan Lei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guangyan Lei. Guangyan Lei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 2 | |
| 3 | 6 | |
| 4 | 1 | |
| 5 | 7 | |
| 6 | 33 | |
| 7 | 2 | |
| 8 | 6 | |
| 9 | 10 | |
| 10 | 3 | |
| 11 | 24 | |
| 12 | 5 | |
| 13 | 47 | |
| 14 | Associations of deregulation of mir-365 and its target mRNA TTF-1 and survival in patients with NSCLC. | 17 |
| 15 | 75 | |
| 16 | 20 | |
| 17 | Efficacy of Compound Kushen Injection for Cancer-related Fatigue in Patients with Lung Cancer following Chemotherapy | 1 |
| 18 | 10 | |
| 19 | 11 | |
| 20 | [Vitexicarpin affects proliferation and apoptosis in mutated p53 breast cancer cell]. | 8 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.